SCHEMBL11330727

SCHEMBL11330727

O=C(O)c1ccccc1Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1

nearest known ligand 0.82

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ TAS2R14 Q9NYV8 12/20 0.82
▸ ADRA2B P18089 1/20 0.76
▸ ADRA2C P18825 1/20 0.76
▸ AKR1C3 P42330 2/20 0.64
▸ AKR1C2 P52895 2/20 0.64
▸ RXFP1 Q9HBX9 2/20 0.60
▸ GRIK1 P39086 1/20 0.60
▸ FABP4 P15090 1/20 0.58
▸ TTR P02766 1/20 0.57
▸ MPO P05164 1/20 0.57
▸ AKR1B1 P15121 1/20 0.56
▸ AKR1C4 P17516 1/20 0.56
▸ AKR1C1 Q04828 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Flufenamic Acid SCHEMBL17497 0.88 RXFP1 (0.75) TAS2R14ADRA2BADRA2CAKR1C3AKR1C2
Flufenamic Acid SCHEMBL29356958 0.88 RXFP1 (0.75) TAS2R14ADRA2BADRA2CAKR1C3AKR1C2
Flufenamic Acid SCHEMBL11524554 0.87 RXFP1 (0.73) TAS2R14ADRA2BADRA2CAKR1C3AKR1C2
Flufenamic Acid SCHEMBL9845499 0.87 RXFP1 (0.73) TAS2R14ADRA2BADRA2CAKR1C3AKR1C2
SCHEMBL4245559 0.86 MAPK8 (0.67) TAS2R14ADRA2BADRA2CAKR1C3AKR1C2
SCHEMBL28133218 0.83 FABP4 (0.75) TAS2R14ADRA2BADRA2CAKR1C3AKR1C2
Anthracene SCHEMBL7269976 0.82 MAPK8 (0.63) TAS2R14ADRA2BADRA2CAKR1C3AKR1C2
SCHEMBL22720171 0.81 TAS2R14 (0.74) TAS2R14ADRA2BADRA2CAKR1C3AKR1C2
SCHEMBL8416271 0.81 RXFP1 (0.81) RXFP1GRIK1MPO
SCHEMBL6813056 0.80 TAS2R14 (0.77) TAS2R14ADRA2BADRA2CAKR1C3AKR1C2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4273873-A BONDING SYNTHETIC FIBRINOLYTIC COMPOUND OR ENZYME UNITIKA LTD. (JP) 1981-06-16 — — US disclosed
Send feedback